Zweig-DiMenna Associates’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-137,771
Closed -$1.38M 164
2021
Q3
$1.38M Hold
137,771
0.1% 133
2021
Q2
$1.41M Sell
137,771
-229
-0.2% -$2.31K 0.08% 152
2021
Q1
$1.39M Buy
+138,000
New +$1.45M 0.1% 141

Other funds holding CPUH.U

Zweig-DiMenna Associates's CPUH.U Position: Q4 2021 in Review

Zweig-DiMenna Associates sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q4 2021, closing a stake of 137,771 shares — an estimated $1.38M sold.

Zweig-DiMenna Associates first reported a position in CPUH.U in Q1 2021 and held it in 3 quarters. The position peaked at $1.41M in Q2 2021. 42 funds tracked by Wall St. Rank hold CPUH.U as of Q4 2021.

  • Zweig-DiMenna Associates reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 137,771 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q4 2021, an estimated $1.38M.
  • Zweig-DiMenna Associates first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Zweig-DiMenna Associates's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $1.41M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q4 2021.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2021, filed 27 Jan 2022.